Research Papers

25 of 61 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Trends in cell medicine: from autologous cells to allogeneic universal-use cells for adoptive T-cell therapies.
Kawamoto H; Masuda K.
Int Immunol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Peripheral helper T cells, mavericks of peripheral immune responses.
Yoshitomi H.
Int Immunol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Cytokine signaling in chimeric antigen receptor T-cell therapy.
Kagoya Y.
Int Immunol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical…
Kajihara A; Morita T; Kato Y; Konaka H; Murakami T; Yamaguchi Y; Koyama S; Takamatsu H; Nishide M; Maeda Y; Watanabe A; Nishida S; Hirano T; Shima Y; Narazaki M; Kumanogoh A.
Int Immunol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cells.
Tatsuguchi T; Uruno T; Sugiura Y; Sakata D; Izumi Y; Sakurai T; Hattori Y; Oki E; Kubota N; Nishimoto K; Oyama M; Kunimura K; Ohki T; Bamba T; Tahara H; Sakamoto M; Nakamura M; Suematsu M; Fukui Y.
Int Immunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Integrin CD11b provides a new marker of pre-germinal center IgA+ B cells in murine Peyer's patches.
Gao P; Adachi T; Okai S; Morita N; Kitamura D; Shinkura R.
Int Immunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Control of inflammation using non-invasive neuromodulation: past, present and promise.
Tynan A; Brines M; Chavan SS.
Int Immunol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19.
Gao YD; Agache I; Akdis M; Nadeau K; Klimek L; Jutel M; Akdis CA.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development.
Kunimura K; Fukui Y.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021.
Xu K; Dai L; Gao GF.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Macrophages in lung fibrosis.
Ogawa T; Shichino S; Ueha S; Matsushima K.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Neural guidance factors as hubs of immunometabolic cross-talk.
Nakanishi Y; Kang S; Kumanogoh A.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Genetics and animal models of familial pulmonary fibrosis.
Yasutomo K.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Development of COVID-19 vaccines utilizing gene therapy technology.
Nakagami H.
Int Immunol (Unknown)
Published: 2021
1/6 Transparent
COVID-19 and immunity: quo vadis?
Miyasaka M.
Int Immunol (Unknown)
Published: 2021
1/6 Transparent
Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells.
Kiniwa T; Moro K.
Int Immunol (Unknown)
Published: 2021
1/6 Transparent
Selective expression of claudin-5 in thymic endothelial cells regulates the blood-thymus barrier and T-cell export.
Nagatake T; Zhao YC; Ito T; Itoh M; Kometani K; Furuse M; Saika A; Node E; Kunisawa J; Minato N; Hamazaki Y.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Immune metabolism in PD-1 blockade-based cancer immunotherapy.
Kumar A; Chamoto K.
Int Immunol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Assessment of Th1/Th2 cytokines among patients with Middle East respiratory syndrome coronavirus infection.
Alhetheel A; Albarrag A; Shakoor Z; Somily A; Barry M; Altalhi H; Bakhrebah M; Nassar M; Alfageeh MB; Assiri A; Alfaraj SH; Memish ZA.
Int Immunol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells an…
Tachibana M; Watanabe N; Koda Y; Oya Y; Kaminuma O; Katayama K; Fan Z; Sakurai F; Kawabata K; Hiroi T; Mizuguchi H.
Int Immunol (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Tissue-specific autoimmunity controlled by Aire in thymic and peripheral tolerance mechanisms.
Matsumoto M; Tsuneyama K; Morimoto J; Hosomichi K; Matsumoto M; Nishijima H.
Int Immunol (Unknown)
Published: 2020
3/6 Transparent
Data Funding Declared
Metabolic adaptation to glycolysis is a basic defense mechanism of macrophages for Mycobacterium tuberculosis infection.
Osada-Oka M; Goda N; Saiga H; Yamamoto M; Takeda K; Ozeki Y; Yamaguchi T; Soga T; Tateishi Y; Miura K; Okuzaki D; Kobayashi K; Matsumoto S.
Int Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Theoretical modeling reveals that regulatory T cells increase T-cell interaction with antigen-presenting cells for stab…
Yamaguchi T; Teraguchi S; Furusawa C; Machiyama H; Watanabe TM; Fujita H; Sakaguchi S; Yanagida T.
Int Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis.
Hirose S; Lin Q; Ohtsuji M; Nishimura H; Verbeek JS.
Int Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Regulation of signaling mediated by nucleic acid sensors for innate interferon-mediated responses during viral infectio…
Takaoka A; Yamada T.
Int Immunol (Unknown)
Published: 2019
2/6 Transparent
Funding Declared